Company Filing History:
Years Active: 2006-2009
Title: Ki-Jun Jeong: Innovator in Protein Production Technologies
Introduction
Ki-Jun Jeong is a prominent inventor based in Taejon, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of methods for protein production. With a total of 2 patents, his work focuses on improving the efficiency and purity of protein extraction processes.
Latest Patents
One of Ki-Jun Jeong's latest patents provides an expression vector that includes genes encoding OmpF and a desired protein. This invention allows for the extracellular production of desired proteins through a simpler method than conventional techniques. The recombinant expression vector comprises an ampicillin-resistance gene, the OmpF promoter, and the OmpF gene. This method enables the secretory production of OmpF fusion protein to begin simultaneously with cell growth, leading to increased production as cell concentration rises.
Another notable patent involves a recombinant plasmid vector that includes a kanamycin resistance gene, a promoter, an endoxylanase signal sequence, and a human granulocyte colony-stimulating factor (hG-CSF) gene. This invention facilitates the production of high-purity hG-CSF protein from the protein pool secreted by microorganisms. The process simplifies the extraction of hG-CSF protein, making it suitable for use as an active ingredient in anticancer therapy.
Career Highlights
Ki-Jun Jeong is affiliated with the Korea Advanced Institute of Science and Technology, where he continues to advance research in protein production technologies. His innovative approaches have garnered attention in the scientific community, contributing to advancements in biopharmaceuticals.
Collaborations
Ki-Jun Jeong has collaborated with notable researchers, including Sang-Yup Lee, to further enhance the impact of his inventions in the field of biotechnology.
Conclusion
Ki-Jun Jeong's contributions to protein production technologies demonstrate his commitment to innovation in biotechnology. His patents reflect a dedication to improving methods that can significantly benefit the medical and pharmaceutical industries.